Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: A 10-year prospective register of 3,954 patients

Acta Orthopaedica Scandinavica

Volumn 74, Issue 3, 2003, Pages 299-304

  Dahl, Ola E ^a   Gudmundsen, Tor E ^b   Bjørnarå, Bård T ^b   Solheim, Dag M ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Buskerud Central Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HIP FRACTURE; HOSPITALIZATION; HUMAN; INCIDENCE; JOINT SURGERY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; PROSPECTIVE STUDY; RADIODIAGNOSIS; SCINTIGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 0038102698     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016470308540844     Document Type: Article

References (30)

1. Bergqvist D, Benoni G, Bjorgell O, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696-700.
2. Biello D R. Radiological (scintigraphic) evaluation of patients with suspected pulmonary thromboembolism. JAMA 1987; 257: 3257-9.
3. Cohen A T, Baily C S, Alikhan R, Cooper D J. Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty - a meta-analysis. Thromb Haemost 2001; 85: 940-1.
4. Comp P C, Spiro T E, Friedman R J, et al. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. J Bone Joint Surg (Am) 2001; 83: 336-45.
5. Dahl O E. Cardiorespiratory and vascular dysfunction related to major reconstructive orthopedic surgery. Acta Orthop Scand 1997; 68: 607-14.
6. Dahl O E. Thromboembolism and thromboprophylaxis in high risk surgery: facts and assumptions - a topic for emotions? Eur J Anaesthesiol 2000; 17: 343-7.
7. Dahl O E, Pedersen T, Kierulf P, et al. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res 1993; 70: 451-8.
8. Dahl O E, Aspelin T, Lyberg T. The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery. Blood Coag Fibrinolysis 1995; 6: 709-17.
9. Dahl O E, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997; 77: 26-31.
10. Dahl O E, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 2000; 71: 47-50.
11. Eikelboom J W, Quinlan D, Douketis J D. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358: 9-15.
12. Freitas J E, Sarosi M G, Nagle C C, Yeomans M E, Freitas A E, Juni J E. Modified PIOPED criteria used in clinical practice. J Nucl Med 1995; 36: 1573-8.
13. Frostick S P. Death after joint replacement. Haemostasis 2000; 30: 84-7.
14. Geerts W H, Heir J A, Clagett G P, et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S-75S.
15. Gottschalk A, Sostman H D, Coleman R E, et al. Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J Nucl Med 1993; 34: 1119-26.
16. Gudmundsen T E, Vinje B, Pedersen T. Deep vein thrombosis of lower extremities. Diagnosis by real time ultrasonography. Acta Radiol 1990; 31: 473-5.
17. Hull R D, Pineo G F, Francis C, et al. Low-molecular-weight heparin prophylaxis using dalteparin extended out- of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med 2000; 160: 2208-15.
18. Hull R D, Pineo G F, Stein P D, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients after elective hip arthroplasty: a systemic review. Ann Intern Med 2001; 135: 858-69.
19. Lassen M R, Borris L C, Anderson B S, et al. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty - the Danish Prolonged Prophylaxis (DaPP) Study. Thromb Res 1998; 89: 281-7.
20. Lie S A, Engesaeter L B, Havelin L I, Gjessing H K, Vollset S E. Mortality after total hip replacement: 0-10-year follow-up of 39,543 patients in the Norwegian Arthroplasty Register. Acta Orthop Scand 2000; 71: 19-27.
21. McNally M A, Bahadur R, Cooke E A, Mollan R A. Venous hemodynamics in both legs after total knee replacement J Bone Joint Surg (Br) 1997; 79: 633-7.
22. NEMA. Performance measurements of scintillation cameras. NEMA standards publication No. NU 1. National Electrical Manufacturers Association, Washington, DC 1994.
23. Oger E. Incidence of venous thromboembolism: a community-based study in western France. Thromb Haemost 2000; 83: 657-60.
24. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute PE. Results of the prospective investigation of PE diagnosis (PIOPED). JAMA 1990; 263: 2753-9.
25. Planes A, Vochelle N, Darmon J Y, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-8.
26. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-44.
27. Rodger M, Wells P S. Diagnosis of pulmonary embolism. Thromb Haemost 2001; 103: V224-V38.
28. Sandset P E, Dahl O E, Mowinckel M C. Aspelin T. Activated protein C (APC) resistance and risk of venous thromboembolism after elective hip replacement surgery. Thromb Haemost (Suppl) 1999: 589-90.
29. Sostman H D, Coleman R E, DeLong D M, Newman G E, Paine S. Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected PE. Radiology 1994; 193: 103-7.
30. White R H, Romano P S, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158: 1525-31.